AvéUltra is the name of a product made by a different manufacturer, and it was introduced to the market in 2009. This is a very new product that has a short market history.

AvéUltra is completely independent from the products containing the original Avemar Pulvis, which has been manufactured by Biropharma Ltd. since 1998 with unchanged quality. According to the available professional opinions regarding the compositions of AvéUltra and Avé (the product manufactured by Biropharma Ltd. for the U.S. market), the two products are not nearly the same.

It is scientifically proven that the set of compounds used in AvéUltra significantly differs from the set of compounds used in Avé and AWGE. Since AvéUltra does not contain Avemar Pulvis, all of the references made by AvéUltra with respect to in vitro, in vivo and human clinical studies carried out with Avemar Pulvis are deceptive to both patients and their doctors. The toxicity study of AvéUltra is also not available.

In our opinion, the manufacturer of AvéUltra would like to take advantage of the fact that Avé was a successful product and brand by using the name “AvéUltra”.
The product containing the original Avemar Pulvis manufactured by Birophama Ltd. is available in the U.S. market from 2010 under the name AWGE.